pandas is a Python module that's popular in data science and data analysis. It's offers a way to organize data into DataFrames and offers lots of operations you can perform on this data. It was ...

To analyze grouped survival data subject to informative censoring, we propose the following two-part model: a logistic regression model for the hazard for failure, given covariates, and a logistic ...

Scientific Data mandates authors submit datasets to an appropriate public data repository. Data should be submitted to discipline-specific, community-recognised service where available or a generalist ...

The average tenure for a CMO fell again last year: CMOs at 100 of the top U.S. brands held on to their jobs for just 42 months in 2016, down from 44 months in 2015, according to a recent Wall Street ...

Superintendent of Cincinnati Public Schools Shauna Murphy was evaluated by the school board for her ability to boost student academic performance..

− Treatment with Vutrisiran Led to 37- 49% Lower Rates of Gastrointestinal Events, a Multisystem Manifestation of ATTR-CM, Across Multiple Treatment Groups, Compared to Placebo – − Additional Analyses ...

With data as of September 24, 2025, we examine if Taseko Mines Limited(TGB) is consistently building momentum based on AAII's A+ Investor Momentum and Value Scores and Grades.

NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced updated data presentations including new six-year data from the ULTIMATE I & II Phase 3 trials ...

During year 6 of continuous treatment with BRIUMVI the annualized relapse rate was 0.012, equivalent to one relapse occurring every 83 years of patient treatment Overall safety profile of BRIUMVI ...

OpenAI and Google DeepMind demonstrated that their foundation models could outperform human coders — and win — showing that large language models (LLMs) can solve complex, previously unsolved ...

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results of new analyses from the HELIOS-B Phase 3 study of AMVUTTRA ® (vutrisiran), an RNAi ...